Abstract:An outbreak of an unknown infectious pneumonia has recently occurred in Wuhan, China [1]. The pathogen of the disease was quickly identified as a novel coronavirus (SARS-CoV-2, severe acute respiratory syndrome coronavirus 2),andthediseasewasnamedcoronavirusinfectiondisease-19 (COVID-19) [2]. According to theNewCoronavirus Pneumonia Diagnosis Program (5th edition) published by the National HealthCommissionofChina[3],clinicalmanifestationsconsist of four categories: mild, moderate, severe, and critical. To address the social spread of the virus, Dongxihu Fangcang Hospital, which aims to provide centralized treatment and isolation of COVID-19, was built for patients who were confirmed to have themild type of COVID-19. Hospital equipment usually consists of a series of compartments with different medical or technical support functions, with the ability to deliver early treatment. The mild type patients of COVID-19 can recover shortly after appropriate clinical intervention.Inaddition,virusexclusionafterstandardtreatmentis an important factor indetermining theprognosis ofCOVID-19. Routine blood test was inspected among patients in the Dongxihu Fangcang Hospital. This is the most readily available, efficient, and economic method of examination. Blood analysis examined lymphocytes (LYM), platelets (PLT), the neutrophil-to-lymphocyte ratio (NLR), the lymphocyte-to-monocyte ratio (LMR), the platelet-toneutrophil ratio (PNR), and the platelet-to-lymphocyte ratio (PLR). These blood cell counts and ratios are valuable in understanding the systemic inflammatory response. Researches have shown that NLR has a certain value in evaluating in-hospital mortality, poor clinical outcomes, and severity of COVID-19 [4, 5]. However, it has been rarely reported if these laboratory indicators were correlated with viral expression in COVID19 patients. The aim of this study is to retrospectively analyze clinical data of mild COVID-19 patients treated in the Dongxihu Fangcang Hospital. This studywas conducted in order to identify a simple and effective indicator to assess the correlation between viral exclusion in mild COVID-19 patients and simple laboratory indicators. In this way, it may be possible to perform diagnostic risk stratification and graded treatment of COVID-19 patients. All cases were taken from mild COVID-19 patients in the Dongxihu Fangcang Hospital, which is one of the designated hospitals for the COVID-19 issued by local authorities. When the situation in the epidemic area is stable, the Fangcang hospital was closed on March 8, 2020. The patients with negative nucleic acid will be discharged, and the patients with suspected or positive nucleic acid will be transferred to other hospitals for further treatment. By the time of hospital closure, the median length of stay was 22 days. Nucleic acid test results of the patients before admission were all positive for SARS-CoV-2. A total of 289 samples were included in this study. Excluding patients Chi Zhu, Siyuan Yu and Huangwei Zhao contributed equally to this work and should be considered co-first authors.

[Impact of Mild SARS-CoV-2 Infection on Hematological Parameters and Suitability of Apheresis Platelets Donation in Blood Donors]

Serosurvey for SARS-CoV-2 among Blood Donors in Wuhan,China from September to December 2019

SARS-CoV-2 Induced Thrombocytopenia As an Important Biomarker Significantly Correlated with Abnormal Coagulation Function, Increased Intravascular Blood Clot Risk and Mortality in COVID-19 Patients

Analysis of Blood Index Characteristics in COVID-19 Patients and Their Associations with Different Outcomes

Transfusion safety concerns during the COVID-19 pandemic in Taiwan: Altered by evolving control strategies

[Impact of SARS-CoV-2 Infection on Graft Composition and Early Transplant Outcomes Following Allogeneic Hematopoietic Stem Cell Transplantation].

Alterations in Clinical Characteristics of Blood Donors Post COVID-19 Recovery

Recent infection with SARS‐CoV‐2 in donors was associated with a higher incidence of acute graft‐versus‐host disease in recipients undergoing allogeneic haematopoietic stem cell transplantation

Changes in transfusion‐transmissible infection prevalence and demographics among US blood donors during the COVID‐19 pandemic

The impact of the donors' COVID-19 status on the outcomes of allogeneic hematopoietic stem cell transplantation: a multi-center retrospective study

Association between Hematological Parameters and Severity of Covid-19 Infections

Dynamic Assessment of Hematological Parameters as Predictive Biomarkers for Disease Severity and Prognosis in COVID-19 Patients: A Longitudinal Study

Analysis of dynamic disturbance in blood coagulation function of 261 patients with Coronavirus Disease 2019

Assessing the impact of severe acute respiratory syndrome coronavirus 2 infection on hematological parameters

Association between clinical symptoms during the COVID‐19 infection and SARS‐CoV‐2 immunoglobulin G titers in COVID‐19 convalescent whole‐blood donors in China

Characterization and Trajectories of Hematological Parameters Prior to Severe COVID-19 Based on a Large-Scale Prospective Health Checkup Cohort in Western China: a Longitudinal Study of 13-Year Follow-Up

Association Between Concerns About COVID-19 Infection and Blood Donation Intention: Cross-Sectional Survey Study Through a Mobile Communication Platform

The influence of sporadic cases of COVID-19 on the work of Transfusion Department and its countermeasures

Dynamic changes in routine blood parameters of a severe COVID-19 case

Spike and nucleocapsid antibody dynamics following SARS‐CoV‐2 infection and vaccination: Implications for sourcing COVID‐19 convalescent plasma from routinely collected blood donations

Neutrophil-to-lymphocyte Ratio Predicts the Clearance of SARS-CoV-2 RNA in Mild COVID-19 Patients – a Retrospective Analysis from Dongxihu Fangcang Hospital in Wuhan, China